about
Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophoreAmustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell componentsCost implications of implementation of pathogen-inactivated plateletsA patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.Inactivation of Babesia microti in red blood cells and platelet concentrates.Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA.Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione.Zika virus: new emergencies, potential for severe complications, and prevention of transfusion-transmitted Zika fever in the context of co-circulation of arboviruses.Effects of pegylated hamster red blood cells on microcirculation.Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.High-Resolution Single Particle Zeta Potential Characterisation of Biological Nanoparticles using Tunable Resistive Pulse Sensing.Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione.Amustaline (S-303) treatment inactivates high levels of Chikungunya virus in red-blood-cell components.Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification.Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host diseaseInactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technologyTransfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied interventionTransfusion of pathogen-reduced platelet components without leukoreductionInactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
P50
Q27638858-F6ED0FDC-295F-4EA6-AF0A-F29B6A3899BCQ28729789-4B262CB1-BFD7-4304-9F52-7822318EE622Q36404706-864DF867-E0DB-4079-817D-671C7E0FCDC2Q38052141-F38B680B-9014-4A86-9FA6-2DF649869707Q38158233-D84520E5-A0D6-49F1-A527-2C3FAEBA38A1Q40066637-262EF346-EF9C-4CAF-B129-7853E952044CQ40611312-523D6291-113F-48E4-B2C9-A3BB1D0A7C2EQ40962292-EB132FD0-1847-411A-90D9-B1B692D0F826Q41935541-67DCBA4C-552F-49B8-AEF4-354E3823445DQ42345341-46B0CA40-9911-4B3A-8DBB-0A17461FB625Q46063278-480547E2-45B6-4B6F-9F39-036AFCFC0533Q46500516-0CF63EAB-4BA3-4C4A-AEFE-266878387E5BQ47200074-677F0ABE-66F5-4BF6-9468-97970D0B42EFQ47555572-C6D0CCE1-1BEC-45B3-830A-12A5F1573DC6Q47556754-14AE75A8-4361-4299-95DD-FACC54E5752CQ54571259-CEA2E356-F75F-4E96-89C7-76182A8CA061Q88241690-A33B3AFD-5BF9-46C7-A006-6D5160A792A3Q90026917-0DF7CB74-62B6-470F-BAB3-CE41ABEB2CD1Q91864768-24424AD0-3E5F-430E-8817-D2059D882F0DQ92665721-C2EC5796-2DA5-4B0A-8BAE-1B00BB25AF9BQ93219010-F7CF9B7B-1E65-4503-8A47-E6E8955E0825
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adonis Stassinopoulos
@ast
Adonis Stassinopoulos
@en
Adonis Stassinopoulos
@es
Adonis Stassinopoulos
@nl
Adonis Stassinopoulos
@sl
type
label
Adonis Stassinopoulos
@ast
Adonis Stassinopoulos
@en
Adonis Stassinopoulos
@es
Adonis Stassinopoulos
@nl
Adonis Stassinopoulos
@sl
prefLabel
Adonis Stassinopoulos
@ast
Adonis Stassinopoulos
@en
Adonis Stassinopoulos
@es
Adonis Stassinopoulos
@nl
Adonis Stassinopoulos
@sl
P106
P21
P31
P496
0000-0002-5132-2558